Showing results (71-80 of 189) with videos related to
Sort By:
Pageof 19
Kidney International|November 16, 2010
Potential benefits of alkali therapy to prevent GFR loss: time for a palatable 'solution' for the management of CKDVaibhav Sahni, Robert M Rosa, Daniel BatlleMedicina Clinica|August 5, 2008
[Angiotensin converting enzyme 2 and its emerging role in the regulation of the renin angiotensin system]María José Soler, Josep Lloveras, Daniel BatlleClinical Journal of the American Society of Nephrology : CJASN|July 19, 2020
Cuffless Blood Pressure Monitoring: Promises and ChallengesJay A Pandit, Enrique Lores, Daniel BatlleJournal of the American Society of Nephrology : JASN|March 3, 2022
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 InfectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.Iscience|August 23, 2024
Activation of limbal epithelial proliferation is partly controlled by the ACE2-LCN2 pathwayHuimin Jiang, Min Liu, Wending Yang, et al.Clinical Kidney Journal|December 12, 2017
Angiotensinogen as a biomarker of acute kidney injurySheeba Habeeb Ba Aqeel, Alejandro Sanchez, Daniel BatlleBiorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.Thescientificworldjournal|September 2, 2008
Lithium-associated kidney microcystsJennifer Tuazon, David Casalino, Ehteshamuddin Syed, et al.Hypertension (Dallas, Tex. : 1979)|March 27, 2020
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System BlockersA H Jan Danser, Murray Epstein, Daniel BatllePageof 19